Clinical efficacy of intravesical gemcitabine combined with ubenimex in patients with non-muscle-invasive bladder carcinoma after transurethral resection of bladder tumor

OBJECTIVES: To evaluate the clinical value of intravesical gemcitabine combined with immunotherapy in patients with non-muscle-invasive bladder carcinoma (NMIBC) after transurethral resection of bladder tumor (TURBT). METHODS: Eighty patients with non-muscle-invasive urothelial carcinoma treated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Li-jun, Wang, Hai-jiang, Wang, Jia-rong, Yuan, Xiao-fei, Sha, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247758/
https://www.ncbi.nlm.nih.gov/pubmed/35799745
http://dx.doi.org/10.12669/pjms.38.5.4599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247758/
https://www.ncbi.nlm.nih.gov/pubmed/35799745
http://dx.doi.org/10.12669/pjms.38.5.4599

Ejemplares similares